A team of influential venture capitalists and medical researchers with strong ties to Boston’s biotechnology community is putting cash and top-drawer talent into the new wave of stem cell technology.
Wonders may not cease where stem cell treatment is concerned. Recently stem cell treatment has been applied on human, as a case of Phase I trial and the doctors are quite optimistic since it has been successful in animals.
The rules, the agency said, lay out which research is eligible for federal funding and help “ensure that NIH-funded research in this area is ethically responsible, scientifically worthy and conducted in accordance with applicable law.”
Stem cell is all ready to set another array of success story in ophthalmic treatment. Congenital retinal degeneration or retinal degeneration, a major cause of blindness, related to ageing can be repaired by the incorporation of stem cells. It has not been tested clinically till now, but has been successful in animal testing. It promises a bright future.
LOWERING of ejection fraction of heart is a serious case in heart patients. Often people suffer from breathing problems and low heart rate due to lowering of ejection fraction of heart after a person experiences a cardiac attack. But stem cell once again hovered its magic stick round, and it has been seen that regeneration of new heart muscles and veins has improved the percentage about 30%.
STANFORD University, in California, USA, has been the pioneer for many researches in stem cell therapeutics. It is moving very fast, and aiming to make stem cell therapy available to the patients’ bed in almost every other case. Be it cancer or Parkinson’s, stem cell research and Stanford University is becoming synonyms for cure.
A new study conducted on mice by scientists from University of California, San Francisco (UCFS) has identified that an extract derived from bone marrow cells can effectively improve cardiac function after heart attack as bone marrow stem cells does accordingly.
The ban on embryonic stem cell research has pushed back US almost a decade in stem cell research. It feels heavy competition from other European countries and from Australia who has taken the highest leap in this field of research. So why the “Bio tech Giant”- US faltering behind in stem cell research? Its because the last eight year lag.
Scientists at the University of Missouri claimed that they have invented a way to produce embryonic like stem cells from regular cells from a pig’s connective tissue. The new study appeared in a recent issue of the Proceedings of the National Academy of Sciences (PNAS).
US scientists confirmed through week’s Journal of the American Medical Association, that stem cell transplant could help diabetes type I patients to get rid of daily insulin jabs for as long as four years.